It is shown that APOE4 pericytes transition into myofibroblasts that secrete fibronectin, which promotes vascular amyloid accumulation in AD, and elevated TGF-β signaling is identified as the driver of this pericyte-to-myofibroblast transition.
Abstract
Summary Cerebrovascular disease is a major but poorly understood feature of Alzheimer’s disease (AD). The strongest genetic AD risk factor, APOE4, is associated with cerebrovascular degeneration, including vascular amyloid deposition and fibrosis. To uncover how APOE4 promotes cerebrovascular pathology, we assembled a single-cell transcriptomic atlas of human brain vasculature. In APOE4 carriers, pericyte abundance was significantly reduced and accompanied by the emergence of a myofibroblast-like cell population co-expressing contraction and extracellular matrix genes. Immunostaining confirmed non-vascular myofibroblasts in APOE4 human and mouse brains. We show that APOE4 pericytes transition into myofibroblasts that secrete fibronectin, which promotes vascular amyloid accumulation. Computational and experimental analyses identified elevated TGF-β signaling as the driver of this pericyte-to-myofibroblast transition. Inhibition of TGF-β restored pericyte coverage and reduced vascular fibrosis and amyloid to APOE3 levels, revealing a targetable mechanism linking APOE4 to cerebrovascular pathology in AD.
Vascular-associated fibroblasts are a major source of pathogenic APOE4 that drives vascular dysfunction in cerebral amyloid angiopathy and are establish VAF-derived APOE4 as a compartment-specific driver of CAA and cerebrovascular dysfunction.
Fareeha Saadi, Yoonho Cho, Ilia V. Katritch et al.· bioRxiv· 0 citations
It is found that APOE2 expression supports pericyte functionality through increased lipid processing, providing mechanistic insight into the cerebrovascular protective effects of APOE2 in pericytes.
R. Kadir, J. Bons, Genesis Vega Hormazabal et al.· Brain : a journal of neurolo...· 0 citations
Background The Apolipoprotein E4 (APOE4) is the most significant genetic risk factor for late-onset Alzheimer’s disease (AD), but the cellular mechanisms by which it increases vulnerability remain poorly understood. Lipids play a crucial role in membrane organization, vesicle trafficking, and inflammatory signaling in...
Marios G. Krokidis, Ram Sagar, Maja Mustapić et al.· Frontiers in Pharmacology· 0 citations
Summary The apolipoprotein E ε4 (APOE4) allele is the strongest genetic risk factor for late-onset Alzheimer’s disease (AD), yet the mechanistic underpinnings by which it alters human microglial function remain poorly understood. Here, we utilize CRISPR/Cas9-engineered isogenic human induced pluripotent stem cell-deriv...
Y. You, Son N. Nguyen, Sean D. Mann et al.· Research Square· 0 citations
Alzheimer’s disease (AD) is accompanied by profound cerebrovascular dysfunction, yet it remains unclear whether endothelial abnormalities reflect only vascular injury or altered regulatory states connecting vascular remodeling with metabolic and immune function. We integrated human brain transcriptomic and histopatholo...
Atul Kumar, Jian-Qing Zhang, Jada Harvey et al.· bioRxiv· 0 citations
The results indicate that APOE 4/4 alters astrocyte morphological and molecular maturation while promoting inflammation, disturbing glutamate and Aβ handling under basal conditions and suggests that APOE ε4/ε4 genotype disrupts astrocyte development and key processes of cellular homeostasis early in Alzheimer’s disease...
Rebeca Vecino, Eva Díaz-Guerra, E. Arribas-González et al.· bioRxiv· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.